Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Medicinova (MNOV) EBITDA Margin (2021 - 2025)

Medicinova (MNOV) has disclosed EBITDA Margin for 6 consecutive years, with 2470.94% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin changed N/A to 2470.94% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3157.93% through Dec 2025, changed N/A year-over-year, with the annual reading at 2926.83% for FY2025, N/A changed from the prior year.
  • EBITDA Margin for Q4 2025 was 2470.94% at Medicinova, roughly flat from 2473.1% in the prior quarter.
  • The five-year high for EBITDA Margin was 4.87% in Q1 2021, with the low at 9548.08% in Q3 2021.
  • Average EBITDA Margin over 3 years is 2834.22%, with a median of 2453.35% recorded in 2025.